Precise therapeutic gene correction by a simple nuclease-induced double-stranded break-Reference-Cited by-同舟云学术

Precise therapeutic gene correction by a simple nuclease-induced double-stranded break

Published:2019-04 Issue:7753 Volume:568 Page:561-565
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Iyer Sukanya,Suresh Sneha,Guo Dongsheng,Daman Katelyn,Chen Jennifer C. J.,Liu Pengpeng,Zieger Marina,Luk Kevin,Roscoe Benjamin P.,Mueller Christian,King Oliver D.,Emerson Charles P.,Wolfe Scot A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-019-1076-8.pdf

Reference47 articles.

1. Moreira, E. S. et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat. Genet. 24, 163–166 (2000).

2. El-Chemaly, S. & Young, L. R. Hermansky–Pudlak syndrome. Clin. Chest Med. 37, 505–511 (2016).

3. Sfeir, A. & Symington, L. S. Microhomology-mediated end joining: a back-up survival mechanism or dedicated pathway? Trends Biochem. Sci. 40, 701–714 (2015).

4. Bae, S., Kweon, J., Kim, H. S. & Kim, J.-S. Microhomology-based choice of Cas9 nuclease target sites. Nat. Methods 11, 705–706 (2014).

5. Kim, S.-I. et al. Microhomology-assisted scarless genome editing in human iPSCs. Nat. Commun. 9, 939 (2018).

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring factors influencing choice of DNA double-strand break repair pathways;DNA Repair;2024-08

2. Genome editing in the adrenal gland: a novel strategy for treating congenital adrenal hyperplasia;Exploration of Endocrine and Metabolic Diseases;2024-07-09

3. Insights into Prime Editing Technology: A Deep Dive into Fundamentals, Potentials, and Challenges;Human Gene Therapy;2024-07-01

4. Precise Gene Knock‐In Tools with Minimized Risk of DSBs: A Trend for Gene Manipulation;Advanced Science;2024-05-10

5. Autologous gene therapy for hemoglobinopathies: From bench to patient’s bedside;Molecular Therapy;2024-05